All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Occult HBV Infection-33687074

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	33687074	D144G	S	S	Occult HBV Infection	G S I C L	View
2	33687074	G145A	S	S	Occult HBV Infection	G S I C L	View
3	33687074	T123N	S	S	Occult HBV Infection	G S I C L	View
4	33687074	A128V	S	S	Occult HBV Infection	G S C L	View
5	33687074	C121W	S	S	Occult HBV Infection	G S C L	View
6	33687074	E164G	S	S	Occult HBV Infection	G S C L	View
7	33687074	F134L	S	S	Occult HBV Infection	G S C L	View
8	33687074	G130N	S	S	Occult HBV Infection	G S C L	View
9	33687074	G130R	S	S	Occult HBV Infection	G S I C L	View
10	33687074	G159A	S	S	Occult HBV Infection	G S C L	View
11	33687074	I150T	S	S	Occult HBV Infection	G S C L	View
12	33687074	K122R	S	S	Occult HBV Infection	G S C L	View
13	33687074	M133I	S	S	Occult HBV Infection	G S I C L	View
14	33687074	M133L	S	S	Occult HBV Infection	G S I C L	View
15	33687074	M133T	S	S	Occult HBV Infection	G S I C L	View
16	33687074	P120R	S	S	Occult HBV Infection	G S C L	View
17	33687074	P151L	S	S	Occult HBV Infection	G S C L	View
18	33687074	Q129N	S	S	Occult HBV Infection	G S I C L	View
19	33687074	Q129P	S	S	Occult HBV Infection	G S C L	View
20	33687074	S132F	S	S	Occult HBV Infection	G S C L	View
21	33687074	S136Y	S	S	Occult HBV Infection	G S C L	View
22	33687074	T116I	S	S	Occult HBV Infection	G S C L	View
23	33687074	T118V	S	S	Occult HBV Infection	G S C L	View
24	33687074	T125M	S	S	Occult HBV Infection	G S C L	View
25	33687074	T126I	S	S	Occult HBV Infection	G S C L	View
26	33687074	T127P	S	S	Occult HBV Infection	G S I C L	View
27	33687074	T127R	S	S	Occult HBV Infection	G S C L	View
28	33687074	T131N	S	S	Occult HBV Infection	G S C L	View
29	33687074	W165L	S	S	Occult HBV Infection	G S C L	View
30	33687074	Y100C	S	S	Occult HBV Infection	G S I C L	View
31	33687074	Y134F	S	S	Occult HBV Infection	G S C L	View
32	33687074	Y134H	S	S	Occult HBV Infection	G S C L	View
33	33687074	Y134N	S	S	Occult HBV Infection	G S I C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.